Am. Kandoussi et al., Evolution pattern of auto-antibodies against oxidized low-density lipoproteins in renal transplant recipients, NEPHRON, 89(3), 2001, pp. 303-308
An increased degree of oxidative stress in renal transplant recipients and
a possible role of ciclosporin A (Cs-A) immunosuppressive therapy in this p
rocess have already been described. However, prospective data using in vivo
markers and the influence of Cs-A in the oxidizability of low-density lipo
protein (LDL) are scarce. We aimed at investigating in this prospective stu
dy the evolution pattern of auto-antibodies directed against malondialdehyd
e-modified LDL (MDA-LDL) and Cu2+-oxidized LDL in 28 stable renal transplan
t recipients on Cs-A immunosuppressive therapy before and after 3 successiv
e years of renal transplantation. Also, the effect of enrichment of LDL wit
h Cs-A on the susceptibility of LDL to in vitro oxidation was tested. The r
esults showed a significant increase of both auto-antibody titres (MDA-LDL
and Cu2+-oxidized LDL) after 1 year, and the values remained high during th
e 2nd and the 3rd year following transplantation. The yearly mean relative
variations of auto-antibodies against MDA-LDL and Cu2+-oxidized LDL during
the follow-up period were 133, 149, and 137%, and 111, 115, and 117%, respe
ctively. A significant correlation was observed during the 1st year between
Cs-A trough blood level and Cu2+-oxidized LDL auto-antibody: r = 0.04 (p =
0.046). Incorporation of Cs-A into LDL from healthy volunteers showed no c
hanges during the lag phase in comparison with Cs-A-free LDL, indicating th
at Cs-A had no effect on in vitro LDL oxidizability. Our results suggest th
at Cs-A may be involved earlier in the LDL oxidation, but the mechanism by
which it acts is still unclear. Copyright (C) 2001 S. Karger AG, Basel.